Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 4Phase 4 3Phase NA 2Phase 2/3 1Phase 1/2 1

Status

Unknown 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Breast Neoplasms 538Neoplasms 393Prostatic Neoplasms 261Colorectal Neoplasms 253Lung Neoplasms 202Carcinoma, Hepatocellular 177Stomach Neoplasms 162Pancreatic Neoplasms 151Rectal Neoplasms 143Motor Activity 128Colonic Neoplasms 126Carcinoma, Non-Small-Cell Lung 118Uterine Cervical Neoplasms 113Polycystic Ovary Syndrome 96Head and Neck Neoplasms 96Esophageal Neoplasms 92Neoplasm Metastasis 71Brain Neoplasms 68Liver Neoplasms 67Ovarian Neoplasms 65Recurrence 60Urinary Bladder Neoplasms 59Pain 55Fatigue 54Lymphoma 53Endometrial Neoplasms 52Anxiety Disorders 50Melanoma 48Thyroid Neoplasms 47Pain, Postoperative 41

Interventions

Tretinoin 2Etoposide 1Daunorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Leukemia, Promyelocytic, Acute × Clear all
NCT05832320 2024-05-10

Optimum Induction Therapy of Low-risk APL

Peking University People's Hospital

Phase NA Unknown
74 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT01064557 2020-10-14

"AIDA" Protocol (LAP 0493)

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase NA Unknown
1,068 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡